Integra Lifesciences (NASDAQ:IART) 公佈季度每股收益爲$0.97，高於分析師普遍預期的$0.86，增幅達到12.79%。相比去年同期每股收益$0.89，本次業績增長了8.99%。公司季度銷售額爲$4.4264億，未能達到分析師預期的$4.4515億，差距爲0.56%。然而，這一銷售額相比去年同期的$3.9704億增長了11.49%。

以上內容來自Benzinga Earnings專欄，原文如下：

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.86 by 12.79 percent. This is a 8.99 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $442.64 million which missed the analyst consensus estimate of $445.15 million by 0.56 percent. This is a 11.49 percent increase over sales of $397.04 million the same period last year.